Since 1989, ETEX Corporation has developed, manufactured and marketed proprietary, nanocrystalline calcium-phosphate-based biomaterials that promote the repair and regeneration of bone damaged by trauma or disease. Our experience and expertise in bone biology and biomaterials is the foundation for a robust, innovative, market-driven product pipeline.

The current product portfolio of synthetic calcium phosphate based bone substitute materials is rapidly expanding via the accelerated development of versatile carrier technologies and osteoinductive combination products .

The following themes are central to the ETEX mission:

  • Repairing skeletal defects
  • Regenerating bone and soft tissue
  • Enabling controlled delivery of cells, biologics & therapeutic agents
  • Facilitating minimally invasive procedures
  • Developing user and patient friendly systems 
"Endothermic Calcium Phosphate Cement for Tibial Defect Augmentation"
with Thomas A. Russell, MD View full-length video
 

beta and Gamma are the only biomaterials indicated for use with the N-Force Fixation System

News

1/07/14 ETEX Corporation announces appointment of Stephen R. La Neve as President and Chief Executive Officer

5/02/13 ETEX Corporation announces extended Supply Agreement with Knee Creations, LLC

5/22/12 ETEX Corporation to present at 9th World Biomaterial Congress

4/17/12 ETEX Corporation to present at GTC Stem Cell Summit

» more news

Events

Chicago Lower Extremity
Surgical Symposium

October 23-27, Chicago
www.clesf.org

American Association of Hip
and Knee Surgeons

November 8-10, 2013
Dallas, TX
www.aahks.org

The International Society for Fracture Repair Proximal Humerus
Working Group

December 6-8, 2013
Bologna, Italy
www.fractures.com

American Academy of
Orthopaedic Surgeons

March 12-14, 2014
New Orleans, LA
www.aaos.org

» more events

n-force fixation system